Photodynamic therapy in patients with skin metastases of disseminated melanoma

The aim of the study was to evaluate the immediate results of photodynamic therapy (PDT) in patients with intradermal metastases of skin melanoma. The study included 50 patients who received treatment at the department of hyperthermia and photodynamic therapy. The study included 23 (46%) men and 27...

Full description

Saved in:
Bibliographic Details
Main Authors: D. A. Tzerkovsky, N. A. Petrovskaya, A. N. Mazurenko
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2019-04-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/290
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241265900617728
author D. A. Tzerkovsky
N. A. Petrovskaya
A. N. Mazurenko
author_facet D. A. Tzerkovsky
N. A. Petrovskaya
A. N. Mazurenko
author_sort D. A. Tzerkovsky
collection DOAJ
description The aim of the study was to evaluate the immediate results of photodynamic therapy (PDT) in patients with intradermal metastases of skin melanoma. The study included 50 patients who received treatment at the department of hyperthermia and photodynamic therapy. The study included 23 (46%) men and 27 (54%) women with an average age of 60.7±10.4 years. PDT of tumors was carried out 3–4 hours after intravenous administration of a chlorine-based photosensitizer (Photolon) in doses of 1.5–3 mg/kg using a semiconductor laser «UPL-PDT» (Lemt, Belarus, λ=660±5 nm). The exposure doses varied from 100 to 400 J/cm2; power density – from 0.2 to 0.9 W/cm2; power – from 0.25 to 1 W and time of PDT of one focus was dependent on the size and location of the tumor and was 5 to 20 minutes. Evaluation of antitumor efficacy of PDT was carried out according to WHO criteria. The terms of follow-up of patients were between 3 and 23 months. At follow-up observation, 1–3 months after the treatment, complete regression of intradermal metastases of skin melanoma was achieved in 9 (18%) patients, partial – in 28 (56%), process stabilization in 8 (16%) and progression in 5 (10%)) patients. The objective effect was achieved in 74% of patients, the therapeutic – in 90%. PDT can be used in the treatment of intradermal metastases of disseminated skin melanoma with palliative purposes and allows reducing the tumor volume, which significantly improves the quality of life of patients.
format Article
id doaj-art-82a3bbfef2a54d6085fd44d2f3df737e
institution Kabale University
issn 2413-9432
language Russian
publishDate 2019-04-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj-art-82a3bbfef2a54d6085fd44d2f3df737e2025-08-20T04:00:13ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322019-04-0181242810.24931/2413-9432-2019-8-1-24-28158Photodynamic therapy in patients with skin metastases of disseminated melanomaD. A. Tzerkovsky0N. A. Petrovskaya1A. N. Mazurenko2N.N. Alexandrov National Cancer Centre of Belarus, LesnoyN.N. Alexandrov National Cancer Centre of Belarus, LesnoyN.N. Alexandrov National Cancer Centre of Belarus, LesnoyThe aim of the study was to evaluate the immediate results of photodynamic therapy (PDT) in patients with intradermal metastases of skin melanoma. The study included 50 patients who received treatment at the department of hyperthermia and photodynamic therapy. The study included 23 (46%) men and 27 (54%) women with an average age of 60.7±10.4 years. PDT of tumors was carried out 3–4 hours after intravenous administration of a chlorine-based photosensitizer (Photolon) in doses of 1.5–3 mg/kg using a semiconductor laser «UPL-PDT» (Lemt, Belarus, λ=660±5 nm). The exposure doses varied from 100 to 400 J/cm2; power density – from 0.2 to 0.9 W/cm2; power – from 0.25 to 1 W and time of PDT of one focus was dependent on the size and location of the tumor and was 5 to 20 minutes. Evaluation of antitumor efficacy of PDT was carried out according to WHO criteria. The terms of follow-up of patients were between 3 and 23 months. At follow-up observation, 1–3 months after the treatment, complete regression of intradermal metastases of skin melanoma was achieved in 9 (18%) patients, partial – in 28 (56%), process stabilization in 8 (16%) and progression in 5 (10%)) patients. The objective effect was achieved in 74% of patients, the therapeutic – in 90%. PDT can be used in the treatment of intradermal metastases of disseminated skin melanoma with palliative purposes and allows reducing the tumor volume, which significantly improves the quality of life of patients.https://www.pdt-journal.com/jour/article/view/290skin melanomaintradermal metastasesphotodynamic therapy
spellingShingle D. A. Tzerkovsky
N. A. Petrovskaya
A. N. Mazurenko
Photodynamic therapy in patients with skin metastases of disseminated melanoma
Biomedical Photonics
skin melanoma
intradermal metastases
photodynamic therapy
title Photodynamic therapy in patients with skin metastases of disseminated melanoma
title_full Photodynamic therapy in patients with skin metastases of disseminated melanoma
title_fullStr Photodynamic therapy in patients with skin metastases of disseminated melanoma
title_full_unstemmed Photodynamic therapy in patients with skin metastases of disseminated melanoma
title_short Photodynamic therapy in patients with skin metastases of disseminated melanoma
title_sort photodynamic therapy in patients with skin metastases of disseminated melanoma
topic skin melanoma
intradermal metastases
photodynamic therapy
url https://www.pdt-journal.com/jour/article/view/290
work_keys_str_mv AT datzerkovsky photodynamictherapyinpatientswithskinmetastasesofdisseminatedmelanoma
AT napetrovskaya photodynamictherapyinpatientswithskinmetastasesofdisseminatedmelanoma
AT anmazurenko photodynamictherapyinpatientswithskinmetastasesofdisseminatedmelanoma